Filters
Diagnostic markers and pathophysiological mechanisms of atypical parkinsonian syndromes (NT12288)
The project is designed to study clinical and paraclinical markers with a high positive predictive diagnostic value for atypical parkinsonian syndromes and to investigate the contribution of the inhibitory GABA-ergic system in the disorders of gait, ...
FH - Neurologie, neurochirurgie, neurovědy
- 2011 - 2015 •
- 8 122 tis. Kč •
- 8 122 tis. Kč •
- MZ
Řešení projektu: 1. 6. 2011 - 31. 12. 2015
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
New approaches for the prevention of cardiac atrophy studies in rat model heterotopically transplanted heart (NV16-27420A)
Cardiac atrophy is the main detrimental change in fully unloaded heart during the long-term left ventricle assist device (LVAD) support. In view of recent findings that activation of pathways of fatty acid (FA) transport with subsequent increases in ...
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2016 - 2019 •
- 9 627 tis. Kč •
- 9 627 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2016 - 31. 12. 2019
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
The new insight on the pathophysiology of cardiac atrophy after implantation of left ventricular assist device translation studies to define new therapeutic targets (NU22-02-00070)
Cardiac atrophy is a critically important detrimental change in the heart that is unloaded because of long-term left ventricle assist device support. In view of knowledge that there are important sex-related differences in the cardiovascular diseases...
Cardiac and Cardiovascular systems
- 2022 - 2025 •
- 11 218 tis. Kč •
- 11 218 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2022 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Sleep and brain changes related to memory decline in mild cognitive impairment (NV18-07-00272)
The expected aging of the population will increase people with memory disease and dementia, especially Alzheimer's disease. Mild cognitive impairment (MCI) is a risk syndrome in which intervention can delay the development of Alzheimer's disease. Sle...
Clinical neurology
- 2018 - 2022 •
- 9 433 tis. Kč •
- 9 433 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2018 - 30. 6. 2022
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
The effect of gluten-free diet on clinical symptoms, immune parameters and metabolome in neurodegenerative diseases with alfa-synucleinopathy (NU21-04-00443)
Recent data suggest that the brain-gut axis, chronic intestinal inflammation and microbiome may contribute to the pathogenesis of neurodegenerative diseases with alfa-synucleinopathy, which include Parkinson`s disease (PD) and Multiple system atrophy...
Neurosciences (including psychophysiology)
- 2021 - 2025 •
- 13 335 tis. Kč •
- 13 335 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2021 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Myokines and metabolically active molecules in the pathogenesis of idiopathic inflammatory myopathies (NU21-05-00322)
Patients with idiopathic inflammatory myopathies (IIM) suffer from muscle weakness and muscle wasting, a condition in which increased pro-atrophic and decreased anabolic factors, such as myokines myostatin and follistatin, would be expected. However,...
Rheumatology
- 2021 - 2025 •
- 10 887 tis. Kč •
- 10 887 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2021 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Video analysis of hypomimia in Parkinson's disease and other synucleinopathies (NU23J-04-00042)
Currently, no sufficiently accurate diagnostic or progressive biomarker of alfa-synucleinopathy (aSYN) is available that would allow early intervention to prevent the disease progression with potential neuroprotective therapies. Disruption or complet...
Neurosciences (including psychophysiology)
- 2023 - 2026 •
- 6 843 tis. Kč •
- 6 843 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2023 - 31. 12. 2026
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 7 out of 7